Skip to main content

Table 1 Clinical and pathological characteristics of the whole cohort

From: Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization

Characteristics Value
Age (years) Mean (SD) 52.2 (10.6)
Sex Male 1575 (85.3%)
Female 272 (14.7%)
HBV infection No 242 (13.1%)
Yes 1605 (86.9%)
Cirrhosis No 610 (33.0%)
Yes (compensated/decompensated) 1216 (65.9%)/21 (1.1%)
TBil (μmol/L) Mean (SD) 14.6 (6.2)
Child-pugh A 1751 (94.8%)
B 96 (5.2%)
AFP ≤400 ng/mL 1255 (67.9%)
  > 400 ng/mL 592 (32.1%)
γ-GT ≤54 U/L 947 (51.3%)
  > 54 U/L 900 (48.7%)
Transfusion No 1739 (94.2%)
  Yes 108 (5.8%)
Tumor number Single 1499 (81.2%)
  Multiple 348 (18.8%)
Tumor diameter (cm) Mean (SD) 5.8 (3.8)
ES grading I&II 172 (9.3%)
  III&IV 1675 (90.7%)
Capsule Present 1487 (80.5%)
  Absent 360 (19.5%)
Satellite No 1071 (58.0%)
  Yes 776 (42.0%)
MVI Present 644 (34.9%)
  Absent 1203 (65.1%)
BCLC 0 107 (5.8%)
  A 1446 (78.3%)
  B 294 (15.9%)
AJCC Ia 107 (5.8%)
  Ib 938 (50.8%)
  II 623 (33.7%)
  IIIa 179 (9.7%)
CNLC Ia 846 (45.8%)
  Ib 707 (38.3%)
  IIa 203 (11.0%)
  IIb 91 (4.9%)
PA-TACE No 1335 (72.3%)
  Yes 512 (27.7%)
  1. Note: HBV hepatitis B virus, TBil total bilirubin; AFP alpha-fetoprotein; γ-GT gamma-glutamyl transferase; ES Edmondson-Steiner; MVI microvascular invasion; PA-TACE postoperative adjuvant transarterial chemoembolization; AJCC according to the 8th American joint committee on cancer staging; CN CN staging was defined according the Chinese guideline for HCC